CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer. 2021;21(2):139-145.   Published online September 30, 2021
DOI: https://doi.org/10.17998/jlc.2021.09.24

Excel Download

Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma
Immunotherapy of Hepatocellular Carcinoma. 2017;51-68   Crossref logo
Link1

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
Cancers. 2020;12(5):1274   Crossref logo
Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
Pharmaceuticals. 2020;14(1):3   Crossref logo
Link1

The quest for precision oncology with immune checkpoint inhibitors and hepatocellular carcinoma
Journal of Hepatology. 2021;   Crossref logo
Link1 Link2

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Journal of Liver Cancer. 2021;21(2):139-145   Crossref logo
Link1 Link2 Link3

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Cancers. 2021;13(17):4343   Crossref logo
Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
The Oncologist. 2019;24(S1):   Crossref logo
Link1 Link2 Link3

Immune checkpoint inhibitors for hepatocellular carcinoma
Cancer. 2019;125(19):3312-3319   Crossref logo
Link1 Link2 Link3 Link4

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
International Journal of Molecular Sciences. 2020;21(17):6302   Crossref logo
Link1

NOL12 Acts as an Oncogenic Biomarker and Predicts the Efficacy of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
. 2021;   Crossref logo
Link1 Link2